Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation

Area of Science:

• Immunology
• Gastroenterology
• Genetics

Background:

• The nucleotide oligomerization domain 2 (NOD2) 3020insC (NOD2fs) mutation is associated with increased susceptibility to Crohn's disease (CD).
• The precise mechanism by which NOD2fs contributes to CD pathogenesis is debated, with conflicting reports of loss-of-function and gain-of-function phenotypes.
• Understanding the cellular and molecular consequences of NOD2fs is crucial for elucidating its role in inflammatory bowel diseases.

Purpose of the Study:

• To investigate the functional consequences of the NOD2fs mutation in human myeloid dendritic cells (DC).
• To determine how NOD2fs affects DC responses to NOD2 and Toll-like receptor (TLR) ligands.
• To explore the potential role of impaired immune regulation in the context of NOD2fs-associated Crohn's disease.

Main Methods:

• Dendritic cells (DC) were derived from Crohn's disease patients homozygous for the NOD2fs mutation and healthy controls.
• DC responses to purified Toll-like receptor (TLR) ligands and the NOD2 ligand muramyl dipeptide (MDP) were assessed.
• Expression of costimulatory molecules (CD80, CD86) and production of cytokines (TNF-alpha, IL-12, IL-10) were measured.

Main Results:

• Dendritic cells from CD patients with the NOD2fs mutation showed normal responses to TLR ligands.
• These DCs failed to up-regulate CD80 and CD86 costimulatory molecules upon stimulation with MDP.
• MDP-induced enhancement of TLR-mediated TNF-alpha, IL-12, and IL-10 production was absent in NOD2fs DCs compared to controls.

Conclusions:

• The NOD2fs mutation confers a loss-of-function phenotype in human myeloid dendritic cells.
• This impaired response to NOD2 ligands may lead to decreased immune regulation, particularly via reduced IL-10 production.
• These findings suggest a potential mechanism linking the NOD2fs mutation to Crohn's disease susceptibility.